Cargando…

Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes

In vitro studies were undertaken to examine the effects of non-immune porcine peripheral blood leukocytes (PBL) on a Coronavirus infection due to transmissible gastroenteritis virus (TGEV). The assay consisted of TGEV-infected epithelial cells expressing viral antigens on the cell surface and produc...

Descripción completa

Detalles Bibliográficos
Autores principales: Charley, B., Laude, H., La Bonnardière, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134748/
https://www.ncbi.nlm.nih.gov/pubmed/32288183
http://dx.doi.org/10.1016/S0769-2617(87)80003-5
_version_ 1783517901518536704
author Charley, B.
Laude, H.
La Bonnardière, C.
author_facet Charley, B.
Laude, H.
La Bonnardière, C.
author_sort Charley, B.
collection PubMed
description In vitro studies were undertaken to examine the effects of non-immune porcine peripheral blood leukocytes (PBL) on a Coronavirus infection due to transmissible gastroenteritis virus (TGEV). The assay consisted of TGEV-infected epithelial cells expressing viral antigens on the cell surface and producing low amounts of interferon (IFN). Non-immune PBL were found to limit virus replication at an effector-to-target ratio of 100/1 even when effector cells were depleted of phagocytic cells. Neutralizing anti-IFN antibodies did not abrogate the effect. PBL from newborn animals were as effective as adult cells, whereas fibroepithelial cells, human and mouse lymphoid cells did not exert antiviral effects. Under similar conditions, PBL from adult animals could lyse TGEV-infected cells even in the presence of anti-IFN antibodies. However, newborn PBL were not cytotoxic. Moreover, depletion of NK cells by monoclonal antibodies plus complement did not alter the inhibitory effect. These latter observations suggest that virus multiplication-inhibition effects and cytotoxic (or NK) activities are unrelated.
format Online
Article
Text
id pubmed-7134748
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-71347482020-04-08 Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes Charley, B. Laude, H. La Bonnardière, C. Ann Inst Pasteur Virol Article In vitro studies were undertaken to examine the effects of non-immune porcine peripheral blood leukocytes (PBL) on a Coronavirus infection due to transmissible gastroenteritis virus (TGEV). The assay consisted of TGEV-infected epithelial cells expressing viral antigens on the cell surface and producing low amounts of interferon (IFN). Non-immune PBL were found to limit virus replication at an effector-to-target ratio of 100/1 even when effector cells were depleted of phagocytic cells. Neutralizing anti-IFN antibodies did not abrogate the effect. PBL from newborn animals were as effective as adult cells, whereas fibroepithelial cells, human and mouse lymphoid cells did not exert antiviral effects. Under similar conditions, PBL from adult animals could lyse TGEV-infected cells even in the presence of anti-IFN antibodies. However, newborn PBL were not cytotoxic. Moreover, depletion of NK cells by monoclonal antibodies plus complement did not alter the inhibitory effect. These latter observations suggest that virus multiplication-inhibition effects and cytotoxic (or NK) activities are unrelated. Published by Elsevier Masson SAS 1987 2009-09-23 /pmc/articles/PMC7134748/ /pubmed/32288183 http://dx.doi.org/10.1016/S0769-2617(87)80003-5 Text en Copyright © 1987 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Charley, B.
Laude, H.
La Bonnardière, C.
Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title_full Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title_fullStr Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title_full_unstemmed Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title_short Inhibition of transmissible gastroenteritis coronavirus (TGEV) multiplication in vitro by non-immune lymphocytes
title_sort inhibition of transmissible gastroenteritis coronavirus (tgev) multiplication in vitro by non-immune lymphocytes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134748/
https://www.ncbi.nlm.nih.gov/pubmed/32288183
http://dx.doi.org/10.1016/S0769-2617(87)80003-5
work_keys_str_mv AT charleyb inhibitionoftransmissiblegastroenteritiscoronavirustgevmultiplicationinvitrobynonimmunelymphocytes
AT laudeh inhibitionoftransmissiblegastroenteritiscoronavirustgevmultiplicationinvitrobynonimmunelymphocytes
AT labonnardierec inhibitionoftransmissiblegastroenteritiscoronavirustgevmultiplicationinvitrobynonimmunelymphocytes